Live Breaking News & Updates on Pfizer news

Stay informed with the latest breaking news from Pfizer news on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pfizer news and stay connected to the pulse of your community

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease

NEW YORK, March 13, 2024--Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20®, for active immunization for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age.

Espa , Hordaland , Norway , Brazil , Australia , Canada , Liechtenstein , Spain , United-states , Iceland , Italy , Lichtenstein

European Commission Approves Pfizer's PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal Disease -March 13, 2024 at 04:03 am EDT

PREVENAR 20® offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine to help protect infants and children from the 20 serotypes responsible for the majority of...

Espa , Hordaland , Norway , Spain , Liechtenstein , Brazil , Canada , Australia , Italy , United-states , Iceland , Lichtenstein

Pfizer Announces Positive Top-Line Data for Full Season Two Efficacy of ABRYSVO® for RSV in Older Adults

ABRYSVO, a bivalent vaccine, maintained consistently high protective efficacy for both RSV A and RSV B disease through two seasons after a single dose.



ABRYSVO efficacy was 77.8% against RSV...

United-states , Japan , Argentina , Macau , Canada , Alimentosy-tecnolog , Annaliesa-anderson , Pfizer , Administration-bureau-of-macau , Vaccine-research , Health-canada , Regulatory-agency

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer Inc. invites investors and the general public to listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the TD Cowen 44th Annual Health...

David-denton , Health-care-conference-on , Youtube , Pfizer , Linkedin , Pfizer-inc , Exchange-commission , Chief-financial-officer , Executive-vice-president , Annual-health-care-conference , Breakthroughs-that-change-patient , Pfizer-news

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

26.02.2024 - Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with David Denton, Chief Financial Officer, Executive Vice President, at the TD Cowen 44th Annual Health Care Conference on Monday, March 4, 2024 ...

Exchange-commission , Linkedin , Pfizer , Youtube , Breakthroughs-that-change-patient , Pfizer-news , Pfizer-oncology , Annual-report , Looking-information , Factors-that-may-affect-future , Pfizer-stock

Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day

Pfizer Invites Public to Register for Webcast of Pfizer Oncology Innovation Day
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , Youtube , Pfizer-oncology-division , Linkedin , Pfizer , Pfizer-inc , Exchange-commission , Oncology-innovation-day , Pfizer-oncology , Breakthroughs-that-change-patient